SHOCK is a descriptive term used by clinicians to denote a syndrome that is characterized by protracted prostration and hypotension and usually is accompanied by pallor, coldness and moistness of the skin, collapse of superficial veins, alteration of mental status, and suppression of the formation of urine. A mechanism, the results of some recent investigative studies may be cited.
SHOCK is a descriptive term used by clinicians to denote a syndrome that is characterized by protracted prostration and hypotension and usually is accompanied by pallor, coldness and moistness of the skin, collapse of superficial veins, alteration of mental status, and suppression of the formation of urine. A voluminous literature reflects intense disagreement over the meaning and the significance of the term. MIost of this, however, results from the use of a single name to describe a condition produced by many unrelated causes; occasion for disagreement disappears if the term shock is used within the limits of its definition namely, to indicate the clinical state of the patient without specific implication as to the underlying cause.
"Vasomotor collapse" and "peripheral vascular failure" are frequently employed by authors to circumvent the dispute aroused by use of the term shock. These names are subject to the same misunderstanding and add hemodynamic implications that may be misleading. Shock simply refers to the presenting signs of the patient, and within this limit the term is valid and meaningful.
HEMODYNAMIC MIECHAN-ISMS IN SHOCK
In order to give a patient the advantage of rational and effective treatment, it is essential to determine in each case the specific cause of shock. Y et, at the same time, it is possible and helpful to think of a general mechanism that is involved. To illustrate the relationship between a specific mechanism and the general Read at the Continuation Course on Recent Advances in Internal Medicine at the University of Minnesota, March 15, 1957 . mechanism, the results of some recent investigative studies may be cited.
From Overwhelming Infection. The cause of shock that occurs during overwhelming infections due to gram-negative bacteria has been studied in laboratory dogs after intravenous injection of endotoxins derived from Brucella melitensis or EYscherichia coli.1-3 Within 1 minute following such an injection, arterial pressure falls sharply and portal venous pressure increases pronouncedly. The liver and intestines become engorged with blood, suggesting that the fall in arterial pressure and the elevation of the portal venous pressure result from pooling the blood in the splanchnic venous bed. Direct measurements of the change of weight of the liver and intestines indicate that large amounts of blood are pooled in these organs. Measurement of venous flow into the heart demonstrates that the volume of blood returned to the heart is correspondingly decreased. When the cardiac output is determined, a quantitatively similar decline is observed which is the direct cause of the sharp fall in arterial pressure. A secondary and late feature involves electrocardiographic evidence of myocardial ischemia. This is attributed to reduction in blood flow through the coronary arteries because of the sharp decline in arterial pressure. Cardiac failure may be caused by myocardial infarction or cardiac dysrhythmia. Failure of the cardiac pump reduces the cardiac output, sometimes severely enough to produce shock. 5' 6 Hypersensitivity and, particularly, anaphylactic reactions are not completely understood. Present evidence, which is also based on studies in dogs, indicates that shock associated with these phenomena is mainly the result of sudden constriction of small hepatic veins followed by pooling of large quantities of blood in the portal venous bed, which leads to sudden reduction in venous return and cardiac output.7 Thus the initial hemodynamic disturbance is similar to that of shock associated with bacteremia, already described in some detail.
In the absence of normal vasoconstrictive This situation, which is referred to as "irreversible shock" by some authors, is not unlike that which exists in bacteremic shock, a feature that has been stressed by Fine and his coworkers. ' 28 These coincident findings with respect to cardiac rhythm were interesting in themselves, and especially so in relation to the recent studies by Bellet, Wasserman, and Brody.29 These authors reported that molar solution of sodium lactate increases the ventricular rate in patients with Stokes-Adams disease and proposed it for the treatment of this condition. It seems likely that the effectiveness of molar solutions of lactate is due, at least in part, to the increased activity of endogenous epinephrine and norepinephrine which is brought about by elevation of blood pH.
In order to separate the effect on cardiac rhythm from vasopressor effect, these same agents were administered to dogs subjected to total cardiac bypass. After the heart was excluded from the circulation, pressor responses under conditions of respiratory acidosis were uniformly much less than those obtained in the same animal after the pH was returned to or near normal levels. 28 Effect of Molar Lactate in Patients. It was decided then to study at the bedside the value of correcting the acidosis by infusion of a molar solution of lactate. Six patients who had coexisting bacteremic shock and acidosis were treated. All six had received large doses of levarterenol or metaraminol before the studies, but in spite of this the mean arterial blood pressure was rarely more than 40 to 60 mm. Hg. The pH of arterial blood prior to treatment was as low as 7.06; following administration of 300 to 1,000 ml. of molar solution of sodium lactate, the pH was elevated to a maximal value of 7.51. During and after the intravenous administration of sodium lactate the blood pressure returned to near the normal range even though the infusion of vasopressor agents was decreased or discontinued. None of the patients survived for more than 7 days in spite of this treatment. However, it was significant that response to the vasopressor agents was restored by sodium lactate after the usual measures had failed. 30 In view of the limited accumulation of clinical experience on the use of sodium lactate in the treatment of shock, conclusions regarding its value and the possible dangers involved in its use must await additional observations. For the present, it seems worthy of trial when all else has failed. Molar solution of sodium lactate is administered by continuous intravenous infusion at a rate of 5 On the basis of studies in dogs, development of "irreversibility" in shock has been attributed to the formation of minute thrombi that impede blood flow through vital capillary beds, especially in the lung. 46 Increased fibrinolytic activity of plasma is observed during shock and is interpreted by some workers as a compensatory response to such intravascular clotting. 47 The increased coagulability may be due to the release of thromboplastic agents in the blood stream from injured and ischemic tissue. Experimental proof of these explanations is incomplete. Griffith48 stated that heparinization of patients with shock increases their chance for survival, presumably by the prevention of thrombosis in small vessels. As yet, however, the value of this mode of treatment is unconfirmed. 30 -degree head-up position appears to be much more satisfactory, with reliance on more specific measures to maintain blood flow to the brain and other vital organs.
SUMMARY
In the handling of a patient with shock it is essential to identify the underlying cause in order to plan rational treatment. On the basis of information presently available, the specific causes of shock have been classified into 6 groups: hypovolemia, cardiac failure, bacteremia, hypersensitivity, neurogenic factors, and obstruction to blood flow. Treatment was discussed with reference to these groups.
Vasopressor agents are helpful in most instances of shock related to cardiac failure, bacteremia, and hypersensitivity. They usually are contraindicated in shock due to vascular obstruction and in hypovolemic shock until optimal replacement of fluid has been achieved. Recent studies have indicated that metaraminol may be the pressor amine of choice because it is therapeutically effective, simple to administer, without risk of injury to skin and subcutaneous tissues, and available for injection without additional fluid (thus especially suitable for patients with renal failure).
Rigorous attention to the fluid and electrolyte state is of special importance. In the presence of acidosis, the response to vasopressor agents is greatly diminished. The use of molar solution of sodium lactate to re-establish this responsiveness has met with limited success and seems worthy of trial in selected cases.
Adrenocortical hormones may be of striking benefit in shock due to bacteremia or hypersensitivity when an overwhelming response to inflammation threatens life. These drugs may be used also to augment the effectiveness of vasopressor drugs. Relatively little risk is involved, provided that the periods of employment are short and that antibiotics are used concurrently.
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